[ORGANIZATION]
University of Lübeck
Featured in 3 tracked stories · first seen
Situations
[QUIET]
[HEALTH]
Tozorakimab clinical trials for COPD
2 clusters · 2 sources · last updated
Latest: Tozorakimab shows sustained COPD exacerbation reduction in 104-week study
Clinical trial analyses for tozorakimab, an investigational anti-interleukin-33 monoclonal antibody, have demonstrated efficacy in treating chronic obstructive pulmonary disease (COPD). Initial integrated analysis of th
Also covered in
-
University of Lübeck develops AI-driven robotic ultrasound system
[TECHNOLOGY] · 3 sources ·